Imaging spectrum of sudden athlete cardiac death

Clinical Radiology

Volumn 66, Issue 3, 2011, Pages 203-223

  Arrigan, M T ^a   Killeen, R P ^a   Dodd, J D ^b   Torreggiani, W C ^a  

^a Adelaide and Meath Hospital   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANGIOCARDIOGRAPHY; AORTA RUPTURE; AORTA STENOSIS; ARRYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY; ATHLETE; CARDIOMYOPATHY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY; CORONARY ARTERY ANOMALY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART SARCOIDOSIS; HEART TUMOR; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IDIOPATHIC DISEASE; IMAGE ANALYSIS; MITRAL VALVE PROLAPSE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SARCOIDOSIS; SCREENING TEST; SUDDEN DEATH;

ADOLESCENT; ADULT; ALGORITHMS; AORTIC VALVE STENOSIS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ATHLETES; CARDIOMYOPATHY, DILATED; CHEST PAIN; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; MASS SCREENING; MITRAL VALVE PROLAPSE; MYOCARDITIS; SARCOIDOSIS; SYNCOPE; YOUNG ADULT;

EID: 79551644311     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2010.10.011     Document Type: Review

References (179)

1. J.J. Goldberger, M.E. Cain, and S.H. Hohnloser American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council and Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation 118 2008 1497 1518
2. C.M. Pratt, P.S. Greenway, and M.H. Schoenfeld Exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials Circulation 93 1996 519 524
3. B.J. Maron, J.J. Doerer, and T.S. Haas Sudden death in young competitive athletes. Analysis of 1866 deaths in the United States, 1980-2006 Circulation 119 2009 1085 1092
4. B.J. Maron, T.E. Gohman, and D. Aeppli Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes J Am Coll Cardiol 32 1998 1881 1884
5. B.J. Maron Cardiovascular risks to young persons on the athletic field Ann Intem Med 129 1998 379 386
6. R.J. Shepard Mass ECG screening of young athletes Br J Sports Med 42 2008 707 708
7. D. Corrado Essay: sudden death in young athletes Lancet 366 2005 S45 S46
8. F. Quigley A survey of the causes of sudden death in sport in the Republic of Ireland Br J Sports Med 34 2000 258 261
9. B.J. Maron Sudden death in young athletes N Eng J Med 349 2003 1064 1075
10. D. McAuley Does preseason screening for cardiac disease really work? the British perspective Med Sci Sports Exercise 30 1998 S345 S350
11. D.P. Zipes, and H.J.J. Wellens Sudden cardiac death Circulation 98 1998 2334 2351
12. R.E. Eckart, S.L. Scoville, and C.L. Campbell Sudden death in young adults: a 25-year review of autopsies in military recruits Ann Intern Med 141 2004 829 834
13. B.J. Maron Causes of sudden death in competitive athletes J Am Coll Cardiol 7 1986 204 214
14. D. Corrado, C. Basso, and M. Schiavon Screening for hypertrophic cardiomyopathy in young athletes N Engl J Med 339 1998 364 369
15. A. Bouchama, and J.P. Knochel Heat stroke N Engl J Med 346 2002 1978 1988
16. J.A. Kark, D.M. Posey, and H.R. Schumacher Sickle-cell trait as a risk factor for sudden death in physical training N Engl J Med 317 1987 781 787
17. B.J. Maron, L.C. Poliac, and J.A. Kaplan Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities N Engl J Med 333 1995 337 342
18. B.J. Maron, J. Shirani, and L.C. Poliac Sudden death in young competitive athletes clinical, demographic, and pathological profiles JAMA 276 1996 199 204
19. A. Wiste, and T. Messner Symptoms preceding sudden cardiac death in the young are common but often misinterpreted Scand Cardiovasc J 39 2005 143 149
20. B.J. Maron, J.M. Gardin, and J.M. Flack Prevalence of hypertrophic cardiomyopathy in a general population of young adults Circulation 92 1995 785 789
21. A.J. Marian, and R. Roberts Recent advances in the molecular genetics of hypertrophic cardiomyopathy Circulation 92 1995 1336 1347
22. P. Spirito, P. Bellone, and K.M. Harris Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
23. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
24. H.G. Klues, A. Schiffers, and B.J. Maron Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy J Am Coll Cardiol 26 1995 1699 1708
25. H. Niimura, L.L. Bachinski, and S. Sangwatanaroj Mutations in the gene for human cardiac myosin binding protein C and late-onset familial hypertrophic cardiomyopathy N Engl J Med 338 1998 1248 1257
26. H. Watkins, W.J. McKenna, and L. Thierfelder The role of cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy N Engl J Med 332 1995 1058 1064
27. A.M. Varnava, P.M. Elliott, and N. Mahon Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy Am J Cardiol 88 2001 275 279
28. R. Krams, M.J. Kofflard, and D.J. Duncker Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodelling of the coronary microcirculation Circulation 97 1998 230 233
29. L.K. Williams, M.P. Frenneaux, and R.P. Steeds Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management Eur J Echocard 10 2009 iii9 iii14
30. L.C. Afonso, J. Bernal, and J.J. Bax Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies J Am Coll Cardiol Img 1 2008 787 800
31. B.J. Maron, J.S. Gottdiener, and L.W. Perry Specificity of systolic anterior motion of anterior mitral leaflet for hypertrophic cardiomyopathy. Prevalence in large population of patients with other cardiac diseases Br Heart J 45 1981 206 212
32. B.J. Maron, and S.E. Epstein Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet Am J Cardiol 45 1980 141 154
33. B.J. Maron, S.E. Epstein, and S. Betocchi Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303 (Pubitemid 36119984)
34. E.D. Wigle, H. Rakowski, and B.P. Kimball Hypertrophic cardiomyopathy: clinical spectrum and treatment Circulation 92 1995 1680 1692
35. T.S. Kato, A. Noda, and H. Izawa Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography Circulation 110 2004 3808 3814
36. J.L. Posma, P.K. Blanksma, and E.E. van der Wall Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography Am Heart J 132 1996 1020 1027
37. J.D. Allison, F.W. Flickinger, and J.C. Wright Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography Magn Reson Imaging 11 1993 329 334
38. J.H. Park, Y.M. Kim, and J.W. Chung MR imaging of hypertrophic cardiomyopathy Radiology 185 1992 441 446
39. C. Rickers, N.M. Wilke, and M. Jerosch-Herold Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 2005 855 861
40. S.E. Petersen, J.B. Selvanayagam, and J.M. Francis Differentiation of athletes heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance J Cardiovasc Magn Reson 7 2005 551 558
41. M.W. Hansen, and N. Merchant MRI of hypertrophic cardiomyopathy: part I, MRI appearances AJR Am J Roentgenol 189 2007 1335 1343
42. J.C. Moon, N.G. Fisher, and W.J. McKenna Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart 90 2004 645 649
43. J.C. Moon, W.J. McKenna, and M. McCrohon J Perry Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
44. J.C. Moon, E. Reed, and M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
45. L. Chowdhury, H. Mahrholdt, and A. Wagner Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164
46. K. Teraoka, M. Hirano, and H. Ookubo Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy Magn Reson Imaging 22 2004 155 161
47. A.S. Adabag, B.J. Maron, and E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
48. M.S. Maron, T.H. Hauser, and E. Dubrow Right ventricular involvement in hypertrophic cardiomyopathy Am J Cardiol 100 2007 1293 1298
49. D.J. Pennell, U.P. Sechtem, and C.B. Higgins Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report Eur Heart J 25 2004 1940 1965
50. S.J. Dong, J.H. MacGregor, and A.P. Crawley Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study Circulation 90 1994 1200 1209
51. E. Jackson, N. Bellenger, and M. Seddon Ischaemic and non-ischaemic cardiomyopathies - cardiac MRI appearances with delayed enhancement Clin Radiol 62 2007 395 403
52. E. Ghersin, J. Lessick, and D. Litmanovich Comprehensive multidetector CT assessment of apical hypertrophic cardiomyopathy Br J Radiol 79 2006 e200 e204
53. M. Yamamuro, E. Tadamura, and S. Kubo Cardiac functional analysis with multi-detector row CT and segmental reconstruction algorithm: comparison with echocardiography, SPECT and MR imaging Radiology 234 2005 381 390
54. F. Cecchi, I. Olivotto, and R. Gistri Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 349 2003 1027 1035
55. B.J. Maron, A. Pellica, and P. Spirito Cardiac disease in young trained athletes. Insights into methods from distinguishing athletes heart from structural heart disease with a particular emphasis of hypertrophic cardiomyopathy Circulation 91 1995 1596 1601
56. B.J. Maron, W.J. McKenna, and G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
57. P. Spirito, A. Pelliccia, and M.A. Proschan Morphology of the "athletes heart" assessed by echocardiography in 947 elite athletes representing 27 sports Am J Cardiol 74 1994 802 806
58. B.J. Maron Structural features of the athlete heart as defined by echocardiography J Am Coll Cardiol 7 1986 190 203
59. B.J. Maron, J.S. Gottdiener, and S.E. Epstein Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide-angle, two-dimensional echocardiographic study of 125 patients Am J Cardiol 48 1981 418 428
60. B.J. Maron, J.S. Gottdiener, and R.O. Bonow Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography: identification by wide-angle, two-dimensional echocardiography Circulation 63 1981 409 418
61. A. Pelliccia, B.J. Maron, and A. Spataro The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes N Engl J Med 324 1991 295 301
62. A.L. Baggish, F. Wang, and R.B. Weiner Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athlete J Appl Physiol 104 2008 1121 1128
63. A. Pelliccia, B.J. Maron, and A. Spataro Absence of left ventricular hypertrophy in athletes engaged in intense power training Am J Cardiol 72 1993 1048 1054
64. D. Vinereanu, N. Florescu, and N. Sculthorpe Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes Am J Cardiol 88 2001 53 58
65. S.F. Nagueh, L.L. Bachinski, and D. Meyer Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy Circulation 104 2001 128 130
66. C. Basso, D. Corrado, and F. Marcus Arrhythmogenic right ventricular cardiomyopathy Lancet 373 2009 1289 1300
67. C. Basso, G. Thiene, and D. Corrado Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis? Circulation 94 1996 983 991
68. G. Thiene, and C. Basso Arrhythmogenic right ventricular cardiomyopathy. An update Cardiovasc Pathol 10 2001 109 111
69. R. Macedo, K. Prakasa, and C. Tichnell Marked lipomatous infiltration of the right ventricle: MRI findings in relation to arrhythmogenic right ventricular dysplasia AJR Am J Roentgenol 188 2007 W423 W427
70. A.P. Burke, A. Farb, and G. Tashko Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 97 1998 1571 1580
71. D.K. Tansey, Z. Aly, and M.N. Sheppard Fat in the right ventricle of the normal heart Histopathology 46 2005 98 104
72. J.P. van Tintelen, M.M. Entius, and Z.A. Bhuiyan Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy Circulation 113 2006 1650 1658
73. P. Kirchhof, L. Fabritz, and M. Zwiener Age-and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice Circulation 114 2006 1799 1806
74. W.J. McKenna, G. Thiene, and A. Nava Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology Br Heart J 71 1994 215 218
75. D.M. Yoerger, F. Marcus, and D. Sherrill Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. New insights from the multidisciplinary study of right ventricular dysplasia J Am Coll Cardiol 45 2005 860 865
76. F.I. Marcus, W.J. McKenna, and D. Sherrill Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the task force criteria Circulation 121 2010 1533 1541
77. A. Nava, B. Bauce, and C. Basso Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy J Am Coll Cardiol 36 2000 2226 2233
78. M. Midiri, M. Finazzo, and M. Brancato Arrhythmogenic right ventricular dysplasia: MR features Eur Radiol 7 1997 307 312
79. D.A. Bluemke, E.A. Krupinski, and T. Ovitt MR imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability Cardiology 99 2003 153 162
80. S.S. Chowdhry, S.K. Prasad, and P. Syrris Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited comparison with task force criteria and genotype J Am Coll Cardiol 48 2006 2132 2140
81. H. Calkins Arrhythmogenic right ventricular dysplasia Trans Am Clin Climatol Assoc. 119 2008 273 288
82. J.B. White, R. Razmi, and H. Nath Relative utility of magnetic resonance imaging and right ventricular angiography to diagnose arrhythmogenic right ventricular cardiomyopathy J Interv Card Electrophysiol 10 2004 19 26
83. A. Farzaneh-Far, and B.B. Lerman Idiopathic ventricular outflow tract tachycardia Heart 91 2005 136 138
84. D. ODonnell, D. Cox, and J. Bourke Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia Eur Heart J 24 2003 801 810
85. A. Luk, E. Ahn, and G.S. Soor Dilated cardiomyopathy: a review J Clin Pathol 62 2009 219 225
86. J.A. Towbin, and N.E. Bowles The failing heart Nature 415 2002 227 233
87. P. Elliot Diagnosis and management of dilated cardiomyopathy Heart 84 2000 106 112
88. L. Mestroni, B. Maisch, and W.J. McKenna Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy Eur Heart J 20 1999 93 102
89. A. Pelliccia, F. Culasso, and F.M. Di Paolo Physiologic left ventricular cavity dilatation in elite athletes Ann Intern Med 130 1999 23 31
90. M. Stout Athletes heart and echocardiography: athletes heart Echocardiography 25 2008 749 754
91. S. Neubauer, D. Revel, and A. Albert de Roos Task Force of the European Society of Cardiology, in collaboration with the Association of European Paediatric Cardiologists. The clinical role of magnetic resonance in cardiovascular disease Eur Heart J 19 1998 19 39
92. N.E. Doherty, N. Fujita, and G.R. Caputo Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging Am J Cardiol 69 1992 1223 1228
93. R.C. Semelka, E. Tomei, and S. Wagner Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle Am Heart J 119 1990 1367 1373
94. J.A. McCrohon, J.C. Moon, and S.K. Prasad Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59
95. R.J. Kim, T.S. Albert, and J.H. Wible for the Gadoversetamide Myocardial Infarction Imaging Investigators. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial Circulation 117 2008 629 637
96. P.G. Danias, A.W. Ahlberg, and B.A. Clark Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy Am J Cardiol 82 1998 1253 1258
97. T. Yeuqin, L. Xiujie, and S. Rongfang Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy CMJ 5 2000 392 395
98. B.A. Rybicki, M. Major, and J. Popovich Jr. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization Am J Epidemiol 145 1997 234 241
99. K.J. Silverman, G.M. Hutchins, and B.H. Bulkley Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis Circulation 58 1978 1204 1211
100. A.R. Doughan, and B.R. Williams Cardiac sarcoidosis Heart 92 2006 282 288
101. M.C. Iannuzzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165
102. W.C. Roberts, H.A. McAllister Jr., and V.J. Ferrans Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 2) Am J Med 63 1977 86 108
103. J.P. Smedema, G. Snoep, and M.P.G. van Kroonenburgh The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis Chest 128 2005 1629 1637
104. D. Burstow, A. Tajik, and K. Barley Two-dimensional echocardiographic findings in systemic sarcoidosis Am J Cardiol 63 1989 478 482
105. H. Valantine, W.J. McKenna, and P. Nihoyannopoulos Sarcoidosis: a pattern of clinical and morphological presentation Br Heart J 57 1987 256 263
106. L.J. Haywood, O.P. Sharma, and M.E. Siegel Detection of myocardial sarcoidosis by thallium 201 imaging J Natl Med Assoc 74 1982 959 964
107. K. Okayama, C. Kurata, and K. Tawarahara Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis Chest 107 1995 330 334
108. B.H. Bulkey, R. Rouleau, and J.Q. Whitaker The use of thallium-201 for myocardial imaging in sarcoid heart disease Chest 72 1977 27 32
109. A.S. John, T. Dill, and R.R. Brandt Magnetic resonance to assess the aortic valve area in aortic stenosis. How does it compare to current diagnostic standards? J Am Coll Cardiol 42 2003 519 526
110. D. Le Guludec, F. Menad, and M. Faraggi Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy Chest 106 1994 1675 1682
111. T. Shimada, K. Shimada, and T. Sakane Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging Am J Med 110 2001 520 527
112. W. Okumura, T. Iwasaki, and T. Toyama Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis J Nucl Med 45 2004 1989 1998
113. L.T. Cooper Jr. Myocarditis N Engl J Med 360 2009 1526 1538
114. J.W. Magnani, and G.W. Dec Myocarditis: current trends in diagnosis and treatment Circulation 113 2006 876 890
115. G. Fontaine, P. Fornes, and F. Fontaliran Myocarditis as a cause of sudden death Circulation 103 2001 e12
116. H.T. Aretz, M.E. Billingham, and W.D. Edwards Myocarditis: a histopathologic definition and classification Am J Cardiovasc Pathol 1 1987 3 14
117. K.L. Baughman Diagnosis of myocarditis: death of Dallas criteria Circulation 113 2006 593 595
118. N. Hadi, H.N. Skouri, and G.W. Dec Noninvasive imaging in myocarditis J Am Coll Cardiol 48 2006 2085 2093
119. J.M. Hare, and K.L. Baughman Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification Eur Heart J 22 2001 269 270
120. S. Gupta, D.W. Markham, and M.H. Drazner Fulminant myocarditis Nature Clin Pract Cardiovasc Med 5 2008 693 706
121. G.M. Felker, J.P. Boehmer, and R.H. Hruban Echocardiographic findings in fulminant and acute myocarditis J Am Coll Cardiol 36 2000 227 232
122. B. Pinamonti, E. Alberti, and A. Cigalotto Echocardiographic findings in myocarditis Am J Cardiol 62 1988 285 291
123. L.A. Mendes, G.W. Dec, and M.H. Picard Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis Am Heart J 128 1994 301 307
124. E. Lieback, I. Hardouin, and R. Meyer Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis Eur Heart J 17 1996 135 142
125. A. Urhausen, M. Kindermann, and M. Bohm Images in cardiovascular medicine. Diagnosis of myocarditis by cardiac tissue velocity imaging in an Olympic athlete Circulation 108 2003 e21 e22
126. G.W. Dec, I. Palacios, and T. Yasuda Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis J Am Coll Cardiol 16 1990 97 104
127. Z.J. Margari, M.I. Anastasiou-Nana, and J. Terrovitis Indium-111 monoclonal antimyosin cardiac scintigraphy in suspected active myocarditis: evolution and diagnostic impact Int J Cardiol 90 2003 239 245
128. M.G. Friedrich, U. Sechtem, and J. Schulz-Menger International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis Cardiovascular magnetic resonance in myocarditis: a JACC White Paper J Am Coll Cardiol 53 2009 1475 1487
129. M.G. Friedrich, O. Strohm, and J. Schulz-Menger Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis Circulation 97 1998 1802 1809
130. M.G. Gagliardi, B. Polletta, and P. DiRenzi MRI for the diagnosis and follow-up of myocarditis Circulation 99 1999 458 459
131. F. De Cobelli, M. Pieroni, and A. Esposito Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias J Am Coll Cardiol 47 2006 1649 1654
132. G.H. Roditi, G.G. Hartnell, and M.C. Cohen MRI changes in myocarditis - evaluation with spin echo, cine MR angiography and contrast enhanced spin echo imaging Clin Radiol 55 2000 752 758
133. M. Hauser Congenital anomalies of the coronary arteries Heart 91 2005 1240 1245
134. S. Frohner Evaluation of the coronary anomaly, fistula, aneurysm and dissection B. Ohnesorge, T.G. Flohr, C.R. Becker, A. Knez, M.F. Reiser, Multi-slice and dual source CT in cardiac imaging 2nd ed. 2007 Springer Berlin 245 250
135. F.C. Basilico Cardiovascular disease in athletes Am J Sports Med 27 1999 108 121
136. G.F. Greil, M. Stuber, and R.M. Botnar Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease Circulation 105 2002 908 911
137. S. Achenbach, and W.G. Daniel Noninvasive coronary angiography - an acceptable alternative? N Engl J Med 345 2001 1909 1910
138. J.M. Miller, C.E. Rochitte, and M. Dewey Diagnostic performance of coronary angiography by 64-row CT N Engl J Med 359 2008 2324 2336
139. K.E. Fleischmann, M.G. Hunink, and K.M. Kuntz Exercise cardiography of exercise SPECT imaging? A meta-analysis of dianostic test performance JAMA 280 1998 913 920
140. I. Ringvist, L.D. Fisher, and M. Mock Prognostic value of coronary artery disease from the Coronary Artery Surgery Study (CASS) J Clin Invest 71 1983 1854 1866
141. L.L. Leape, R.E. Park, and T.M. Bashore Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures Am Heart J 139 2003 106 113
142. K. Detre, E. Wright, and M. Murphy Observer agreement in evaluating coronary angiograms Circulation 52 1975 979 986
143. L. Zir, S. Miller, and R. Dinsmore Interobserver variability in coronary angiography Circulation 53 1976 627 632
144. R.M. Fleming, R.L. Kirkeeide, and R.W. Smailing Patterns in visual interpretation of coronary angiograms as detected by quantitative coronary angiography J Am Coll Cardiol 18 1991 945 951
145. R. Vas, N. Eigler, and C. Miyazono Digital quantification eliminates intraobserver and inter-observer variability in the evaluation of coronary artery stenosis Am J Cardiol 56 1985 718 723
146. G.M. Stiel, L.S. Stiel, and J. Schofer Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease Circulation 80 1989 1603 1609
147. J. Datta, C.S. White, and R.C. Gilkeson Anomalous coronary arteries in adults: depiction at multi-detector row CT angiography Radiology 235 2005 812 818
148. A.R. Deibler, R.S. Kuzo, and M. Vohringer Imaging of congenital coronary anomalies with multislice computed tomography MayoClinProc 79 2004 1017 1023
149. T. Ishikawa, and P.W. Brandt Anomalous origin of the left main coronary artery from the right anterior aortic sinus: angiographic definition of anomalous course Am J Cardiol 55 1985 770 776
150. T.P. Graham, D.J. Driscoll, and W.M. Gersony Task force 2: congenital heart disease J Am Coll Cardiol 45 2005 1326 1333
151. W.E. Moshage, S. Achenbach, and B. Seese Coronary artery stenosis: three-dimensional imaging with electrocardiographically triggered contrast agent-enhanced, electron-beam CT Radiology 196 1995 707 714
152. J.D. Schuijf, L.J. Shaw, and W. Wijns Cardiac imaging in coronary artery disease: differing modalities Heart 91 2005 1110 1117
153. J.D. Schuijf, J.J. Bax, and L.J. Shaw Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multi-slice computed tomography for non-invasive coronary angiography Am Heart J 151 2006 404 411
154. P.K. Vanhoenacker, M.H. Heijenbrok-Kal, and R. Van Heste Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis Radiology 244 2007 419 428
155. W.J. Manning, W. Li, and R.R. Edelman A preliminary report comparing magnetic resonance angiography with conventional angiography N Engl J Med 328 1993 828 832
156. D.A. Bluemke, S. Stephan Achenbach, and M. Budoff Noninvasive coronary artery imaging magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young Circulation 118 2008 586 606
157. J.C. Post, A.C. van Rossum, and J.G. Bronzwaer Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 92 1995 3163 3171
158. H.W. Vliegen, J. Doornbos, and A. de Roos Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies Am J Cardiol 79 1997 773 776
159. N.H. Bunce, C.H. Lorenz, and J. Keegan Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography Radiology 227 2003 201 208
160. W.Y. Kim, P.G. Danias, and M. Stuber Coronary magnetic resonance angiography for the detection of coronary stenoses N Engl J Med 345 2001 1863 1869 (Pubitemid 33716560)
161. S. Mavrogeni, G. Papadopoulos, and M. Douskou Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease J Am Coll Cardiol 43 2004 649 652
162. H. Kato, T. Sugimura, and T. Akagi Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients Circulation 94 1996 1379 1385
163. B.A. Carabello Aortic stenosis N Engl J Med 346 2002 677 682
164. G.M. Feuchtner, W. Dichtl, and G.J. Friedrich Multislice computed tomography for detection of patients with aortic valve stenosis and quantification of severity J Am Coll Cardiol 47 2006 1410 1417
165. C. Adele, P.T. Vaitkus, and M.D. Tischler Evaluation of the significance of a transvalvular catheter on aortic valve gradient in aortic stenosis: a direct hemodynamic and Doppler echocardiographic study Am J Cardiol 79 1997 513 516
166. E. Hayek, C.N. Gring, and B.P. Griffin Mitral valve prolapse Lancet 365 2005 507 551
167. L.A. Freed, D. Levy, and R.A. Levine Prevalence and clinical outcome of mitral-valve prolapse N Engl J Med 341 1999 1 7
168. F. Grigioni, M. Enriquez-Sarano, and L.H. Ling Sudden death in mitral regurgitation due to flail leaflet J Am Coll Cardiol 34 1999 2078 2085
169. R.O. Bonow, B.A. Carabello, and K. Chatterjee ACC/AHA 2006 guidelines for the management of patients with valvular heart disease a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anaesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J Am Coll Cardiol 48 2006 598 675
170. R.A. Levine, E. Stathogiannis, and J.B. Newell Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality J Am Coll Cardiol 11 1988 1010
171. Y. Han, D.C. Peters, and C.J. Salton Cardiovascular magnetic resonance characterization of mitral valve prolapse J Am Coll Cardiol 1 2008 294 303
172. B.J. Maron, P.D. Thompson, and M.J. Ackerman Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update Circulation 115 2007 1643 1655
173. D. Corrado, C. Basso, and A. Pavei Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program JAMA 296 2006 1593 1601 (Pubitemid 44515020)
174. J.M.G. Wilson, and G. Jungner Principles and practice of screening for disease. Public health papers no. 34 1968 World Health Organization Geneva
175. A. Pelliccia, and B.J. Maron Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience Am J Cardiol 75 1995 827 829
176. A.P. Burke, A. Farb, and R. Virmani Sports-related and non-sports-related sudden cardiac death in young adults Am Heart J 121 1991 568 575
177. D. Corrado, A. Pelliccia, and H.H. Bjornstad Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J 26 2005 516 524 (Pubitemid 40326204)
178. B.J. Maron, P.D. Thompson, and M.J. Ackerman Recommendations and considerations related to pre-participation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation Circulation 115 2007 1643 1655
179. G. Quarta, P. Lambiase, and P. Elliott Identification of family members at risk: beyond sudden death in the athlete Br J Sports Med 2009 10.1136/bjsm.2009.067512